Literature DB >> 17105229

Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer.

Shuang Liu1, Zhengjie He, Wen-Yuan Hsieh, Young-Seung Kim, Young Jiang.   

Abstract

This report describes synthesis of three new cyclic RGDfK peptide conjugates, HYNIC-PKM-SU016 (PKM = E, K and PEG4) and in vivo evaluation of the impact of PKM linkers on biodistribution characteristics of their ternary ligand complexes [99mTc(HYNIC-PKM-SU016)1(tricine)(TPPTS)] in athymic nude mice bearing the MDA-MB-435 human breast cancer xenografts. Results from biodistribution studies show that PKM linkers have minimal impact on the integrin alphavbeta3 binding capability of radiotracers. Even though they have different charges under physiological conditions, all three linkers (E, K, and PEG4) are able to reduce the uptake of 99mTc-labeled E[c(RGDfK)]2 in blood, kidneys, liver, and lungs, and increase target-to-background (T/B) ratios at >30 min postinjection. E and K may have advantages over PEG4 due to a combination of relatively low liver uptake and high tumor/liver and tumor/lung ratios of ternary ligand complexes [99mTc(HYNIC-PKM-SU016)(tricine)(TPPTS)] (PKM = E and K).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105229      PMCID: PMC2562319          DOI: 10.1021/bc060235l

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  32 in total

1.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  The role of coordination chemistry in the development of target-specific radiopharmaceuticals.

Authors:  Shuang Liu
Journal:  Chem Soc Rev       Date:  2004-08-16       Impact factor: 54.564

3.  Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.

Authors:  R Haubner; H J Wester; U Reuning; R Senekowitsch-Schmidtke; B Diefenbach; H Kessler; G Stöcklin; M Schwaiger
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

4.  microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

Authors:  Yun Wu; Xianzhong Zhang; Zhengming Xiong; Zhen Cheng; Darrell R Fisher; Shuang Liu; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

Review 5.  Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Authors:  Shuang Liu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

6.  MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.

Authors:  Xiaoyuan Chen; Shuang Liu; Yingping Hou; Michel Tohme; Ryan Park; James R Bading; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2004 Sep-Oct       Impact factor: 3.488

7.  Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.

Authors:  Thomas D Harris; Shirley Kalogeropoulos; Tiffany Nguyen; Shuang Liu; Judit Bartis; Charles Ellars; Scott Edwards; David Onthank; Paula Silva; Padmaja Yalamanchili; Simon Robinson; Joel Lazewatsky; John Barrett; Jeffrey Bozarth
Journal:  Cancer Biother Radiopharm       Date:  2003-08       Impact factor: 3.099

Review 8.  Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Authors:  Roland Haubner; Hans-Jürgen Wester
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

9.  18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.

Authors:  Xiaoyuan Chen; Ryan Park; Anthony H Shahinian; Michel Tohme; Vazgen Khankaldyyan; Mohammed H Bozorgzadeh; James R Bading; Rex Moats; Walter E Laug; Peter S Conti
Journal:  Nucl Med Biol       Date:  2004-02       Impact factor: 2.408

Review 10.  Multimodality imaging of tumor integrin alphavbeta3 expression.

Authors:  Xiaoyuan Chen
Journal:  Mini Rev Med Chem       Date:  2006-02       Impact factor: 3.862

View more
  18 in total

1.  Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers.

Authors:  Jiyun Shi; Lijun Wang; Young-Seung Kim; Shizhen Zhai; Zhaofei Liu; Xiaoyuan Chen; Shuang Liu
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 2.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

3.  Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.

Authors:  Sudipta Chakraborty; Jiyun Shi; Young-Seung Kim; Yang Zhou; Bing Jia; Fan Wang; Shuang Liu
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

4.  Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.

Authors:  Haixun Guo; Yubin Miao
Journal:  J Nucl Med       Date:  2014-11-07       Impact factor: 10.057

5.  Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.

Authors:  Haixun Guo; Jianquan Yang; Fabio Gallazzi; Yubin Miao
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

6.  2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.

Authors:  Jiyun Shi; Young-Seung Kim; Sudipta Chakraborty; Bing Jia; Fan Wang; Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-07-15       Impact factor: 4.774

Review 7.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

8.  Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.

Authors:  Bing Jia; Zhaofei Liu; Jiyun Shi; Zilin Yu; Zhi Yang; Huiyun Zhao; Zhengjie He; Shuang Liu; Fan Wang
Journal:  Bioconjug Chem       Date:  2007-12-11       Impact factor: 4.774

9.  Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.

Authors:  Jiyun Shi; Young-Seung Kim; Shizhen Zhai; Zhaofei Liu; Xiaoyuan Chen; Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

10.  99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.

Authors:  Jiyun Shi; Lijun Wang; Young-Seung Kim; Shizhen Zhai; Bing Jia; Fan Wang; Shuang Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-30       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.